KLRK1 and acute myeloid leukemia: In line with these findings we have observed diminished expression of the activating NK receptors NKp30, NKp46 and NKG2D as well as a lower capacity of NK cells to produce IFN-γ in untreated AML patients at the time of diagnosis.